Belkacemi, Y.; Debbi, K.; Coraggio, G.; Bendavid, J.; Nourieh, M.; To, N.H.; Cherif, M.A.; Saldana, C.; Ingels, A.; De La Taille, A.;
et al. Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer. Cancers 2023, 15, 945.
https://doi.org/10.3390/cancers15030945
AMA Style
Belkacemi Y, Debbi K, Coraggio G, Bendavid J, Nourieh M, To NH, Cherif MA, Saldana C, Ingels A, De La Taille A,
et al. Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer. Cancers. 2023; 15(3):945.
https://doi.org/10.3390/cancers15030945
Chicago/Turabian Style
Belkacemi, Yazid, Kamel Debbi, Gabriele Coraggio, Jérome Bendavid, Maya Nourieh, Nhu Hanh To, Mohamed Aziz Cherif, Carolina Saldana, Alexandre Ingels, Alexandre De La Taille,
and et al. 2023. "Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer" Cancers 15, no. 3: 945.
https://doi.org/10.3390/cancers15030945
APA Style
Belkacemi, Y., Debbi, K., Coraggio, G., Bendavid, J., Nourieh, M., To, N. H., Cherif, M. A., Saldana, C., Ingels, A., De La Taille, A., & Loganadane, G.
(2023). Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer. Cancers, 15(3), 945.
https://doi.org/10.3390/cancers15030945
